Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and -3 Clinical Trials
2016 ◽
Vol 63
(8)
◽
pp. 1042-1048
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2016 ◽
Vol 150
(4)
◽
pp. S1267-S1268
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 212
(3)
◽
pp. 367-377
◽
Keyword(s):
2017 ◽
pp. 1-10
◽